TGFB1 and hepatocellular carcinoma: Interestingly, the OS curves show a particular pattern: patients with low-TGF-β1 HCC were likely to experience early-stage survival within 20 months, whereas those with low-TG2 HCC were likely to experience late-stage survival (Figure 5D).